Treating the Resistant Patent Ductus Arteriosus (PDA) - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Treating the Resistant Patent Ductus Arteriosus (PDA)

This study is not yet open for participant recruitment.

Study NCT00616382 Information provided by Shaare Zedek Medical Center

First Received: January 13, 2008 Last Updated: February 14, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)

Publications:

Sperandio M, Beedgen B, Feneberg R, Huppertz C, Brüssau J, Pöschl J, Linderkamp O. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation. Pediatrics. 2005 Dec;116(6):1361-6.

Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr. 1996 Apr;128(4):470-8.

Back to top of Main Content